FY 22 Notes
- We should have started the capex bit earlier (little more conservative , due to this we were unable to supply)
- Current Capex will take us to 500cr Revenue (need to make capex for the growth beyond this )
- Sulphones – One of the Sulphones doing pretty well and completely sold out (large room for growth, not yet made any investments on that )
- Electronic Chemicals – There is not enough demand in India || In India air quality and water quality is not conducive to make electronic chemicals
- Future capex is on Specialty chemicals
- 2/3 capex is borrowing
- 5 Phds working in R&D and QC
- Two New products commercially launched last year – did reasonably well, expect to grow in coming years
- Export – Specialty chemicals did well
- EU-Ukraine Crisis – This a area for concern , no direct problem to DMCC but for all the global companies
- RM Prices – Gone up substantially in last 12 months (Pass increases are passed on but unable to do on Bulk Chemicals)
- Roha – Carbon negative (will achieve this in Dahej as well)
- Boron – Capacity is not fully utilized due to raw material shortage
- 400 people working on Roha and Dahej
- Setting up new R&D lab in Roha and Dahej
- We are strong in Sulphur and Boron chemistry , don’t see we are going into other chemistries
- 1-1.5x asset turnover on bulk chemicals, specialty 2-2.5x asset turnover
- We don’t rely on Ukraine or Russia for RM
- Borrowings are USD, EUR and INR terms
- Bulk plant running at 90% capacity
- Immediately two capex plans
- We don’t burn too much of power, we rely on heat recovery , dahej grid independent will achieve this at roha as well
- Sulphuric acid plant – 350 Ton at Roha – 350 Ton at Dahej (no need to make any investment in this for next 5-10 years)
- In three products we are top in the world
Subscribe To Our Free Newsletter |